June 3, 2024 · Form 4 insider transaction
WAGNER CHARLES F JR sold 3,250 shares of Vertex Pharmaceuticals Incorporated at $460.00 per share, a transaction worth $1.50M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 02/26/2024.